Nanordica Medical
PrivateLast Round
Early Funding
Jun 10, 2026
Total Funding Raised
$8.41M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nanordica Medical operates in Healthcare & Life Sciences and is based in Tallinn. Its latest recorded funding round was an Early Funding round in June 2026.
Nanordica Medical is a medtech company that develops advanced antibacterial wound care products based on nanotechnology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanordica Medical Comparables
Compare Nanordica Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MedCu | 84% | |
| GelSana Therapeutics | 81% | |
| Smith & Nephew | 73% |
For institutional investors. Book with your work email.
Nanordica Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 10, 2026 | ||||
| Seed | May 16, 2024 | ||||
| Grant | Feb 1, 2024 | ||||
| Seed | Feb 6, 2023 | ||||
| Grant | Jun 15, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nanordica Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Superangel | Seed |
| European Innovation Council Fund | Grant |
| Verge HealthTech Fund | Seed |
| Estonian Business Angels Network | Early Funding |
| Health Founders | Early Funding, Seed |
| AS Amalfi | Seed |
| Specialist VC | Early Funding, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 162% MoM.
- Jun 10, 2026
$1.84M raised, led by 2C Ventures.
For institutional investors. Book with your work email.
Nanordica Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanordica Medical's valuation, stock price, and market status.
Is Nanordica Medical a public or private company?
Nanordica Medical is a private company.
What is the current stock price of Nanordica Medical?
Nanordica Medical is a private company, so its shares have no public market price. Caplight tracks Nanordica Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanordica Medical worth (valuation)?
Valuation information for Nanordica Medical is not publicly available.
Can I buy Nanordica Medical stock?
Nanordica Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanordica Medical's last funding round?
Nanordica Medical's most recent funding round was Early Funding on June 10, 2026.
Who are the main investors in Nanordica Medical?
Key investors in Nanordica Medical include Specialist VC, 2C Ventures.
Will Nanordica Medical IPO soon?
No public IPO plans have been announced for Nanordica Medical.
How can I track Nanordica Medical secondary market activity?
Caplight tracks bids, offers, and trades in Nanordica Medical's shares on secondary markets.